Literature DB >> 629600

Ankylosing spondylitis and inflammatory bowel disease. I. Prevalence of inflammatory bowel disease in patients suffering from ankylosing spondylitis.

S G Meuwissen, B J Dekker-Saeys, D Agenant, G N Tytgat.   

Abstract

To establish the prevalence of inflammatory bowel disease in ankylosing spondylitis (AS), 79 AS patients underwent detailed medical screening, including sigmoidoscopic and roentgenological examination, 48 had gastrointestinal symptoms and the others did not. In 3 patients a diagnosis of Crohn's disease was made which was previously established. In all other patients inflammatory bowel disease could be excluded. The prevalence of inflammatory bowel disease in this series of patients with AS therefore was 3.8%.

Entities:  

Mesh:

Year:  1978        PMID: 629600      PMCID: PMC1000184          DOI: 10.1136/ard.37.1.30

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  12 in total

Review 1.  The aetiology of Crohn's disease.

Authors:  G N Tytgat; C J Mulder
Journal:  Int J Colorectal Dis       Date:  1986-07       Impact factor: 2.571

2.  Increased numbers of IgG-containing cells in rectal lamina propria of patients with ankylosing spondylitis.

Authors:  M A Stodell; R C Butler; V A Zemelman; K Henry; D A Brewerton
Journal:  Ann Rheum Dis       Date:  1984-04       Impact factor: 19.103

3.  Prevalence of occult inflammatory bowel disease in ankylosing spondylitis.

Authors:  P B Costello; J A Alea; A C Kennedy; R T McCluskey; F A Green
Journal:  Ann Rheum Dis       Date:  1980-10       Impact factor: 19.103

4.  Inflammatory bowel disease and ankylosing spondylitis associated with cutaneous vasculitis, glomerulonephritis, and circulating IgA immune complexes.

Authors:  A J Peeters; A W van den Wall Bake; M R Daha; F C Breeveld
Journal:  Ann Rheum Dis       Date:  1990-08       Impact factor: 19.103

5.  Diet, disease activity, and gastrointestinal symptoms in patients with ankylosing spondylitis.

Authors:  Björn Sundström; Solveig Wållberg-Jonsson; Gunnar Johansson
Journal:  Clin Rheumatol       Date:  2010-11-27       Impact factor: 2.980

6.  Indomethacin-induced intestinal ulcers in rats: effects of salicylazosulfapyridine and dexamethasone.

Authors:  P Del Soldato; D Foschi; L Varin; S Daniotti
Journal:  Agents Actions       Date:  1985-07

7.  Clinical and radiographic features of spondylitic hip disease.

Authors:  J S Marks; K Hardinge
Journal:  Ann Rheum Dis       Date:  1979-08       Impact factor: 19.103

8.  Ankylosing spondylitis and inflammatory bowel disease. III. Clinical characteristics and results of histocompatibility typing (HLA B27) in 50 patients with both ankylosing spondylitis and inflammatory bowel disease.

Authors:  B J Dekker-Saeys; S G Meuwissen; E M Van Den Berg-Loonen; W H De Haas; K A Meijers; G N Tytgat
Journal:  Ann Rheum Dis       Date:  1978-02       Impact factor: 19.103

9.  The colon in patients with ankylosing spondylitis and in normal controls in Bangladesh: a macroscopic and microscopic study.

Authors:  Md Nazrul Islam; Mir Mahfuzul Hoque Chowdhury; Syed Atiqul Haq; Mohammad Kamal; Anwarul Kabir; Mahmud Hasan; Johannes J Rasker
Journal:  Clin Rheumatol       Date:  2009-10-21       Impact factor: 2.980

10.  An analysis of the gastro-intestinal side-effects of non-steroidal anti-inflammatory drugs, with particular reference to comparative studies in man and laboratory species.

Authors:  K D Rainsford
Journal:  Rheumatol Int       Date:  1982       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.